NIH Awards John Kim, MD, $3.2 Million to Identify Blood Protein Biomarkers for Pulmonary Fibrosis
9/23/2025
John Kim, MD, an assistant professor of medicine in the Division of Pulmonary and Critical Care Medicine, was awarded a five-year $3.2 million NIH grant to identify blood protein biomarkers…
Discovery Suggests How Immune Cells May Drive Alzheimer’s, Neurological Diseases
9/23/2025
New University of Virginia School of Medicine research has revealed how and why ailing immune cells called microglia may be contributing to Alzheimer’s disease, multiple sclerosis and other neurological disorders.…
UVA Health Launches Statewide Clinical Trials Network
9/23/2025
UVA Health announces the launch of its Clinical Trials Network to improve access to clinical trials across Virginia. In Northern Virginia and surrounding regions, two UVA Health clinical trials are…
Research in Motion: Muge Kuyumcu-Martinez, PhD
9/23/2025
My research is centered on RNA binding proteins that control how heart genes are turned on and off at the RNA level. Mutations in these RNA binding proteins can cause…
UVA Office of the Vice President for Research Sponsors Educational Events
9/16/2025
The Office of the Vice President for Research is sponsoring many educational events in the next few months. U Ask, UVA Answers - Researcher Speaker Series | Central Downtown Library…
Seham Ebrahim, PhD, Awarded $2.4 Million NIH R01 Grant to Advance Male Fertility Research
9/16/2025
Seham Ebrahim, PhD, an assistant professor in the Department of Molecular Physiology and Biological Physics, has been awarded a $2.4 million R01 grant from the Eunice Kennedy Shriver National Institute…
Jeff Smith, PhD, Awarded $2.6 Million to Study Aging and its Impact on Chronic Diseases
9/16/2025
Jeff Smith, PhD, a professor in the Department of Biochemistry and Molecular Genetics, and his lab were recently awarded a five-year, $2.6 million R01 research grant from the NIH -…
Menopause Drug Reduces Hot Flashes by More Than 70% in International Clinical Trial
9/16/2025
The investigational drug elinzanetant significantly reduces hot flashes and night sweats for post-menopausal women, a large, international clinical trial has found. The OASIS-3 trial enrolled more than 600 postmenopausal women,…
